Quaker BioVentures

2929 Arch Street

Philadelphia, PA 19104

215-988-6800

215-988-6801

www.quakerbio.com

Abstract Description

Venture capital firm with an exclusive focus on life science companies.

Management

Brenda D. Gavin, Partner-Richard S. Kollender-Partner,Ira M. Lubert, Partner.

Keywords

Comment | Printable Version | 1 of 1 | |

//

Description

Quaker BioVentures is a venture capital firm investing only in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage businesses to public companies. The firm was formed in 2003 and is currently investing Quaker BioVentures II, which was formed in 2007. Quaker BioVentures manages over $500M in committed capital.

Relevant Relationships

Achillion Amicus Therapeutics BIOLEX Celator Pharmaceuticals CELLATOPE Cempra Medmark NEURONETICS NovaSom NuPathe Precison Therapeutics Protez pharmaceuticals Regado Biosciences Rapidmicro biosystems SEMPRAE TargetRX TARSA therapeutics Tear Science tengion TetraLogic pharmaceuticals TransEnterix tranzyme pharma

2012-02-06-1234 SELECT * FROM `master` WHERE CompanyID='10164' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30